A246710 Share Price Performance
Recent A246710 News & Updates
No updates
T&R Biofab Co., Ltd. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -247.11
- Gross Margin
- 24.95%
- Net Profit Margin
- -55.23%
- Debt/Equity Ratio
- 218.0%
T&R Biofab Co., Ltd. Competitors
About A246710
- Founded
- 2013
- Employees
- 93
- CEO
- WebsiteView website
T&R Biofab Co., Ltd. develops and commercializes various regenerative medical technologies. It offers 3D-printed medical devices; and bio-surgical solutions, which includes wound dressing and acellular dermal matrix, as well as biomaterials and biopharmaceuticals. The company was founded in 2013 and is based in Siheung-si, South Korea.
South Korean Market Performance
- 7 Days: -2.5%
- 3 Months: 19.7%
- 1 Year: 13.3%
- Year to Date: 27.4%
Over the last 7 days, the market has dropped 2.5%, driven by a decline of 8.3% in the Financials sector. In the last year, the market is actually up 13%. Earnings are forecast to grow by 22% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading